Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy.
about
Efficacy and safety of rituximab in Japanese patients with relapsed chronic immune thrombocytopenia refractory to conventional therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Efficacy and safety of rituxim ...... tory to conventional therapy.
@ast
Efficacy and safety of rituxim ...... tory to conventional therapy.
@en
type
label
Efficacy and safety of rituxim ...... tory to conventional therapy.
@ast
Efficacy and safety of rituxim ...... tory to conventional therapy.
@en
prefLabel
Efficacy and safety of rituxim ...... tory to conventional therapy.
@ast
Efficacy and safety of rituxim ...... tory to conventional therapy.
@en
P2093
P2860
P1476
Efficacy and safety of rituxim ...... tory to conventional therapy.
@en
P2093
Kaichi Nishiwaki
Katsutoshi Ozaki
Kayoko Kikuchi
Kingo Fujimura
Masaaki Higashihara
Masakatsu Nishikawa
Shinichiro Okamoto
Shinya Katsutani
Shosaku Nomura
Takahiro Yano
P2860
P2888
P304
P356
10.1007/S12185-015-1887-9
P577
2015-10-14T00:00:00Z
P6179
1052321757